R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Director - Regulatory Affairs

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeMilan, Metropolitan City of Milan, ItalyNo salary listed

About the Job

Requirements

  • A Master's or PhD degree in a scientific or medical discipline.
  • At least 10 years of experience in regulatory leadership roles or a similar role within the pharmaceutical or biotechnology industry.
  • Strong understanding of the regulatory framework in Italy and the European Union.
  • Knowledge and experience in the oncology therapeutic area.
  • Excellent verbal and written communication skills in Italian and English.
  • Ability to analyze and summarize scientific information effectively.
  • Presentation skills with the ability to communicate complex scientific data to diverse audiences.
  • Networking skills with the ability to build and maintain relationships with Italian regulatory bodies and healthcare professionals.
  • Ability to work independently in a fast-paced and dynamic environment.
  • Willingness to travel up to 30% of the time.

Responsibilities

  • Lead and provide strategic input on regulatory activities for assigned projects and territories in accordance with ICH requirements, Italian and European Union regulations, and company policies and procedures.
  • Work cross-functionally with global and European regulatory professionals to support early-stage and marketed products.
  • Ensure compliance with applicant and/or marketing authorization holder responsibilities under applicable legislation and regulatory guidelines for assigned products in Italy.
  • Provide regulatory support for assigned products and therapeutic areas and work with medical affairs, clinical development, marketing, and other teams to execute medical strategies and tactics.
  • Support global and regional regulatory affairs with the preparation and follow-up of national scientific consultations and pre-submission meetings.
  • Coordinate the creation of materials for risk mitigation activities and healthcare professional communication.
  • Ensure product packaging and related information are updated and maintained in accordance with regulatory requirements.
  • Review and approve promotional materials.
  • Represent the regulatory function at internal and external meetings in collaboration with regional and/or global regulatory affairs.
  • Monitor and analyze nationally relevant Italian regulatory guidelines and communicate updates and implications to regional and global teams.
  • Maintain knowledge of complex Italian and European Union regulatory requirements and contribute to, comment on, and communicate changes to regulatory guidelines and information.
  • Participate in industry association groups and regulatory affairs professional societies.
  • Initiate or contribute to local and global process improvements with significant business impact.
  • Lead the creation, maintenance, continuous improvement, training, evaluation, and follow-up of regulatory procedures, including policies, standard operating procedures, manuals, and work instructions.
  • Manage affiliate inspections and audits.
  • Manage quality defects, counterfeit or imitation products, and batch recalls.
  • Serve as the information officer.
  • Maintain responsibility for distribution and wholesale licenses.
  • Manage local regulatory and regulatory compliance audits within the affiliate.
  • Provide vision and direction for the country-level Regulatory Affairs organization in alignment with Global and European Regulatory Affairs and the Italian affiliate's vision.
  • Plan, monitor, allocate, and optimize resources and budget related to portfolio development and regulatory changes.
  • Ensure a well-staffed and appropriately trained affiliate.
  • Understand regulatory requirements for customer engagement by field-based employees.
  • Adhere to Revolution Medicines core values and policies.

Desired Qualifications

  • Preferred experience in oncology.
  • Experience with both early- and late-stage clinical assets and approved therapies.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs